These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 9112987)

  • 1. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis.
    Masinick SA; Montgomery CP; Montgomery PC; Hazlett LD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):910-8. PubMed ID: 9112987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.
    Thakur A; Kyd J; Xue M; Willcox MD; Cripps A
    Infect Immun; 2001 May; 69(5):3295-304. PubMed ID: 11292752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin A antibodies against Pseudomonas aeruginosa in the tear fluid of contact lens wearers.
    Cheng KH; Spanjaard L; Rutten H; Dankert J; Polak BC; Kijlstra A
    Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2081-8. PubMed ID: 8814147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of anti-Pseudomonas aeruginosa specific secretory IgA antibodies in tears of patients with Pseudomonas aeruginosa keratitis].
    Nakashima M; Inada N; Kato H; Shoji J; Sawa M
    Nippon Ganka Gakkai Zasshi; 2013 Dec; 117(12):996-1003. PubMed ID: 24516981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and topical protection studies using Pseudomonas aeruginosa flagella in an ocular model of infection.
    Rudner XL; Hazlett LD; Berk RS
    Curr Eye Res; 1992 Aug; 11(8):727-38. PubMed ID: 1424719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with homologous Pseudomonas aeruginosa pili protects against ocular disease.
    Rudner XL; Berk RS; Hazlett LD
    Reg Immunol; 1993; 5(5):245-52. PubMed ID: 7908533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival.
    Mochizuki Y; Suzuki T; Oka N; Zhang Y; Hayashi Y; Hayashi N; Gotoh N; Ohashi Y
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):240-6. PubMed ID: 24255043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of uniquely glycosylated secretory immunoglobulin a in tears from patients with Pseudomonas aeruginosa keratitis.
    Lomholt JA; Kilian M
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4939-44. PubMed ID: 18757515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic and therapeutic vaccine against Pseudomonas aeruginosa keratitis using bacterial membrane vesicles.
    Ito S; Nakamura J; Fukuta M; Ura T; Teshigawara T; Fukushima J; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 May; 39(23):3152-3160. PubMed ID: 33934918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of a peptide derived from a potential adhesin of Pseudomonas aeruginosa against corneal infection.
    Yuan Q; Wu Y; Wang Y; Chen L; Qu M; Duan K; Zhao G
    Exp Eye Res; 2016 Feb; 143():39-48. PubMed ID: 26500187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection.
    Kernacki KA; Hobden JA; Hazlett LD; Fridman R; Berk RS
    Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1371-8. PubMed ID: 7775115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of bacterial colonization of contact lenses with covalently attached selenium and effects on the rabbit cornea.
    Mathews SM; Spallholz JE; Grimson MJ; Dubielzig RR; Gray T; Reid TW
    Cornea; 2006 Aug; 25(7):806-14. PubMed ID: 17068458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
    Kernacki KA; Barrett R; Hazlett LD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lecithin-bound superoxide dismutase in the prevention of neutrophil-induced damage of corneal tissue.
    Matsumoto K; Shimmura S; Goto E; Saito K; Takeuchi T; Miyajima S; Negi A; Tsubota K
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):30-5. PubMed ID: 9430542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycan involvement in the adhesion of Pseudomonas aeruginosa to tears.
    Kautto L; Nguyen-Khuong T; Everest-Dass A; Leong A; Zhao Z; Willcox MDP; Packer NH; Peterson R
    Exp Eye Res; 2016 Apr; 145():278-288. PubMed ID: 26851486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.
    Hazlett LD; Rudner XL; McClellan SA; Barrett RP; Lighvani S
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):419-24. PubMed ID: 11818386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
    Huang X; Barrett RP; McClellan SA; Hazlett LD
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perlecan in the basement membrane of corneal epithelium serves as a site for P. aeruginosa binding.
    Chen LD; Hazlett LD
    Curr Eye Res; 2000 Apr; 20(4):260-7. PubMed ID: 10806439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.